Author Archive: BIOtechNOW Editor

Wednesday Keynote Luncheon

hrc115x76

Wednesday Keynote Luncheon Today noon-1:30 Hillary Rodham Clinton served as the 67th U.S. Secretary of State from 2009 until 2013, after nearly four decades in public service. Her “smart power” approach to foreign policy repositioned American diplomacy and development for the 21st century. Clinton played a central role in restoring America’s standing in the world, reasserting the United States as a Pacific power, imposing crippling sanctions on Iran and North Korea, responding to the Arab Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

The Most Linked In Man in Biotech Retires after 35 Years

Chris Y

The biotech world loses one of its preeminent titans of business development this year with the retirement of Chris Yochim. Variously dubbed “the face of AstraZeneca”, “Mr. Conference”, and other monikers as colorful as his dress shirts, Chris concludes a career spanning 35 years in the pharmaceutical industry. Trained as a pharmacologist, he contributed to the identification of several candidate compounds that are marketed drugs today, but more than anything else, Chris is known as Read More >

Events  |  1 Comment  |  Email This Post
Tags: , , , , , , , ,

Patent Parameters

Untitled-1

Supreme Court Finds Naturally Occurring DNA to Be Patent Ineligible Last summer, the Supreme Court issued its decision in Association for Molecular Pathology v. Myriad Genetics, Inc., which concerned the patent eligibility of the BRCA1 and BRCA2 genes. In Myriad, a unanimous Supreme Court held that a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated. The Court also determined, albeit with one caveat, that Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Integrate and Collaborate to Drive Advancements in Oncology Treatments

A New Paradigm in Oncology Treatment

Scientific innovation and exploration have driven exciting changes in the pharmaceutical industry’s understanding of cancer, from improvements in screening to the development of more personalized, treatments. In a 2014 BIO International Convention Super Session on Tuesday moderated by BioCentury Editor Susan Schaeffer, panelists discussed the pressing need for companies to increase collaboration with each other and with industry stakeholders, including patient advocacy groups and academic medical centers, to speed the development and delivery of new Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Turning the Tide on STEM Education

family_115x76

According to the US Department of Education, only 16 percent of American high school seniors are proficient in mathematics and interested in a career in a Science, Technology, Engineering or Math (STEM) field. Even among students who do major in a STEM field, only about half go on to work in a related career. As an industry, we have a responsibility to not only prepare today’s students for careers in STEM fields but also to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,